RTI Pooling Methods Conflict With Tissue Practices Rule - CBER

Regeneration Technologies, Inc.' s BioCleanse system for pooling tissue from multiple donors is not validated to conform to FDA's Jan. 8 proposed rule on good tissue practices, FDA states in a May 3 letter to the firm.

More from Archive

More from Medtech Insight